Tacrograf 0.25mg Tacrolimus Capsules

Product Description

• Indication: Prevents organ rejection post-transplant
• Active Ingredient: Tacrolimus 0.25mg
• Mechanism of Action: Suppresses T-cell activation to prevent immune response
• Dosage Form: Capsule (Oral)
• Administration: Taken twice daily, as prescribed
• Side Effects: Hypertension, kidney issues, increased infection risk
• Precaution: Requires regular monitoring of blood levels
• Tacrograf 0.25mg contains Tacrolimus (0.25mg), a potent immunosuppressant derived from Streptomyces tsukubaensis. It is used primarily to prevent organ rejection in patients who have undergone liver, kidney, heart, and other organ transplants. Tacrograf works by inhibiting T-lymphocyte activation, thereby reducing the risk of the immune system attacking the transplanted organ. It is also effective in treating severe atopic dermatitis when used topically. The medication is available in capsule form and should be taken exactly as prescribed by a healthcare professional. Common side effects include hypertension, kidney dysfunction, and an increased risk of infections due to immune suppression.